<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2512246494
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Lignox
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE,PRILOCAINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5,2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        % (W/W)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Cream
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tube
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        56.40
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAUDI PHARMACEUTICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 1023]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAUDI PHARMACEUTICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N01BB20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lignox contains two active substances called lidocaine and prilocaine. These belong to a group of medicines called local anaesthetics.</p><p>Lignox works by numbing the surface of the skin for a short time. It is put on the skin before certain medical procedures. This helps to stop pain on the skin; however, you may still have the feelings of pressure and touch.</p><p><strong>Adults, Adolescents and Children</strong><br />It can be used to numb the skin before:</p><ul><li>Having a needle put in (for example, if you are having an injection or a blood test).</li><li>Minor skin operations.</li></ul><p><strong>Adults and Adolescents</strong><br />It can also be used:</p><ul><li>To numb the genitals before:<ul><li>Having an injection.</li><li>Medical procedures such as removal of warts.</li></ul></li></ul><p>A doctor or nurse should apply Lignox on the genitals.</p><p><strong>Adults</strong><br />It can also be used to numb the skin before:</p><ul><li>Cleansing or removal of damaged skin of leg ulcers.</li></ul><p>For other purposes than application to intact skin, the product should be used only upon recommendation of a doctor, nurse or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Lignox:</strong></p><ul><li>if you are allergic to lidocaine or prilocaine, other similar local anaesthetics or any of the other ingredients of this medicine (listed in section 6).</li></ul><p><strong>Warnings and precautions</strong><br />Talk to your doctor, pharmacist or nurse before using Lignox:</p><ul><li>if you or your child have a rare inherited illness that affects the blood called &lsquo;glucose-6-phosphate dehydrogenase deficiency&rsquo;.</li><li>If you or your child have a problem with blood pigment levels called &lsquo;methaemoglobinaemia&rsquo;.</li><li>Do not use Lignox on areas with skin rash, cuts, grazes or other open wounds, with the exception of a leg ulcer. If any of these problems are present, check with your doctor, pharmacist or nurse before using the cream.</li><li>If you or your child have an itchy skin condition called &lsquo;atopic dermatitis&rsquo;, a shorter application time may be sufficient. Application times of longer than 30 minutes may result in an increased incidence of local skin reaction (see also section 4 &ldquo;Possible side effects&rdquo;).</li><li>If you take particular products for heart rhythm disorders (class III antiarrhythmics, such as amiodarone). In that case the doctor will monitor your heart function.</li></ul><p>Due to the potentially enhanced absorption on the newly shaven skin, it is important to follow the recommended dosage, skin area and application time.</p><p>Avoid getting Lignox in the eyes, as it may cause irritation. If you accidentally get Lignox in your eye, you should immediately rinse it well with lukewarm water or salt (sodium chloride) solution. Be careful to avoid getting anything in your eye until feeling returns.</p><p>Lignox should not be applied to an impaired eardrum.</p><p>When you use Lignox before being vaccinated with live vaccines (e.g., tuberculosis vaccine), you should return to your doctor or nurse after the time period requested to follow-up the vaccination result.</p><p><strong>Children and adolescents</strong><br />In infants/newborn infants younger than 3 months a transient, clinically not relevant increase in blood pigment levels &ldquo;methaemoglobinaemia&rdquo; is commonly observed up to 12 hours after Lignox is put on.</p><p>The effectiveness of Lignox when drawing blood from the heel of newborn infants or to provide adequate analgesia for circumcision could not be confirmed in clinical studies.</p><p>Lignox should not be applied to the genital skin (e.g., penis) and genital mucosa (e.g., in the vagina) of children (below 12 years of age) owing to insufficient data on absorption of active substances.</p><p>Lignox should not be used in children younger than 12 months of age who are being treated at the same time with other medicines that affect blood pigment levels &ldquo;methaemoglobinaemia&rdquo; (e.g., sulphonamides, see also Section 2 &ldquo;Other medicines and Lignox&rdquo;).</p><p>Lignox should not be used in preterm newborn infants.</p><p><strong>Other medicines and Lignox</strong><br />Tell your doctor or pharmacist if you are using/taking, have recently used/taken or might use/take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Lignox can affect the way some medicines work and some medicines can have an effect on Lignox.</p><p>In particular, tell your doctor or pharmacist if you or your child have recently used or been given any of the following medicines:</p><ul><li>Medicines used to treat infections, called &lsquo;sulphonamides&rsquo; and nitrofurantoin.</li><li>Medicines used to treat epilepsy, called phenytoin and phenobarbital.</li><li>Other local anaesthetics.</li><li>Medicines to treat an uneven heartbeat, such as amiodarone.</li><li>Cimetidine or beta-blockers, which may cause an increase in the blood levels of lidocaine. This interaction is of no clinical relevance in short-term treatment with Lignox in recommended doses.</li></ul><p><strong>Pregnancy, breast feeding and fertility</strong><br />If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p>Occasional use of Lignox during pregnancy is unlikely to have any adverse effects on the foetus.</p><p>The active substances in Lignox (lidocaine and prilocaine) are passed into breast milk. However, the amount is so small that there is generally no risk to the child.</p><p>Animal studies have shown no impairment of male or female fertility.</p><p><strong>Driving and using machines</strong><br />Lignox has no or negligible influence on the ability to drive and use machines when used at the recommended doses.</p><p><strong>Lignox contains macrogolglycerol hydroxystearate</strong><br />Macrogolglycerol hydroxystearate may cause skin reactions</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Lignox exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.</p><p>This product is available in different pack sizes. You will have been provided with a suitable pack size for your intended use.</p><p><strong>Using Lignox</strong></p><ul><li>Where to put the cream, how much to use and how long to leave it on will depend on what it is used for. Half a 5 g tube corresponds to about 2 g Lignox. One gram of Lignox pressed out of a tube of 30 g is approximately 3.5 cm.</li><li>Lignox should be used on the genitals only by a doctor or nurse.</li><li>When Lignox is used on leg ulcers, a doctor or nurse should supervise its use.</li></ul><p><strong>Do not use Lignox on the following areas:</strong></p><ul><li>Cuts, grazes or wounds, excluding leg ulcers.</li><li>Where there is a skin rash or eczema.</li><li>In or near the eyes.</li><li>Inside the nose, ear or mouth.</li><li>In the back passage (anus).</li><li>On the genitals of children.</li></ul><p>Persons frequently applying or removing cream should ensure that contact is avoided in order to prevent the development of hypersensitivity.</p><p>The protective membrane of the tube is perforated by applying the cap.</p><p><strong>&nbsp;Use on the skin before small procedures (such as having a needle put in or minor skin operations):</strong></p><ul><li>The cream is put on to the skin in a thick layer. Follow the instructions on the leaflet or those from your health care professional. In certain cases, your healthcare professional has to apply the cream.</li><li>The cream is then covered by a dressing [plastic wrap]. This is taken off just before the procedure starts. If you are applying the cream yourself, make sure that you have been given dressings by your doctor, pharmacist or nurse.</li><li>The usual dose for adults and adolescents over 12 years is 2 g (grams).</li><li>For adults and adolescents over 12 years put the cream on at least 60 minutes before the procedure (unless the cream is being used on the genitals). However, do not put it on more than 5 hours before.</li></ul><p><strong>Children<br />Use on the skin before small procedures (such as having a needle put in or minor skin operations). </strong>Application time: approx. <strong>1 hour.</strong></p><p><strong><em>Newborn infants and infants 0 &ndash; 2 months: </em></strong>Up to 1 g of cream on a skin area not larger than 10 cm<sup>2</sup> (10 square centimetres) in size. Application time: <strong>1 hour, not more. Only one single dose should be given in any 24-hour period.</strong></p><p><strong><em>Infants aged 3 &ndash; 11 months: </em></strong>Up to 2 g of cream on a total skin area not larger than 20 cm<sup>2</sup> (20 square centimetres) in size. Application time: approx. <strong>1 hour</strong>.</p><p><strong><em>Children aged 1 &ndash; 5 years: </em></strong>Up to 10 g of cream on a total skin area not larger than 100 cm<sup>2</sup> (100 square centimetres) in size. Application time: approx. <strong>1 hour</strong>, maximum 5 hours.</p><p><strong><em>Children aged 6 &ndash; 11 years: </em></strong>Up to 20 g of cream on a total skin area not larger than 200 cm<sup>2</sup> (200 square centimetres) in size. Application time: approx. <strong>1 hour</strong>, maximum 5 hours.</p><p>A maximum of 2 doses at least 12 hours apart may be given to children over 3 months of age in any 24-hour period.</p><p>Lignox can be used on children with a skin condition called &ldquo;atopic dermatitis&rdquo; but the application time is then 30 minutes, no longer.</p><p>When you apply the cream, it is very important to exactly follow the instructions below:</p><ol><li>Squeeze the cream into a mound where it is needed on your skin (for example where the needle is going to be put in). Half a 5 g tube corresponds to about 2 g Lignox. One gram of Lignox pressed out of a tube of 30 g is approximately 3.5 cm. Do not rub the cream in.<br /><img alt="" width="116" height="128" src="data:image/png;base64,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" /></li><li>Peel the paper layer from the &lsquo;centre cut-out&rsquo; of the non-adhesive side of the dressing (leaving a frame of paper).<br /><img alt="" width="128" height="128" src="data:image/png;base64,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" /></li><li>Remove the cover of the adhesive side of the dressing.<br /><img alt="" width="128" height="128" src="data:image/png;base64,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" /></li><li>Place the dressing carefully over the mound of cream. Do not spread the cream under the dressing.<br /><img alt="" width="128" height="125" src="data:image/png;base64,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" /></li><li>Remove the paper backing. Smooth down the edges of the dressing carefully. Then leave it in place for at least 60 minutes if the skin has not been damaged. The cream should not be left in place for more than 60 minutes in children under 3 months or for more than 30 minutes in children with an itchy skin condition called &lsquo;atopic dermatitis&rsquo;. If the cream is used on the genitals or on ulcers, shorter applications times may be used as described below.<br /><img alt="" width="128" height="124" src="data:image/png;base64,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" /></li><li>Your doctor or nurse will take the dressing off and remove the cream just before they do the medical procedure (for example just before the needle is put in).<br /><img alt="" width="128" height="117" src="data:image/png;base64,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" /></li></ol><p><strong>Use on larger areas of newly shaven skin before outpatient procedures (such as hair removal techniques):</strong><br />Follow the instructions from your healthcare professional.</p><p>The usual dose is 1 g of cream for each area of skin that is 10 cm<sup>2</sup> (10 square centimetres) in size, applied for 1 to 5 hours under a dressing. Lignox should not be used on an area of newly shaven skin larger than 600 cm<sup>2</sup> (600 square centimetres, e.g., 30 cm by 20 cm) in size. The maximum dose is 60 g.</p><p><strong>Use on the skin before hospital procedures (such as split-skin grafting) that require deeper skin anaesthesia:</strong></p><ul><li>Lignox can be used in this way on adults and adolescents over 12 years, but only under the supervision of a doctor or nurse.</li><li>The usual dose is 1.5 g to 2 g of cream for each area of skin that is 10 cm<sup>2</sup> (10 square centimetres) in size.</li><li>The cream is put on under a dressing for 2 to 5 hours.</li></ul><p><strong>Use on the skin prior to removal of wart-like spots called &ldquo;mollusca&rdquo;</strong></p><ul><li>Lignox can be used on children and adolescents with a skin condition called &ldquo;atopic dermatitis&rdquo;.</li><li>The usual dose depends on the child&rsquo;s age and is used for 30 to 60 minutes (30 minutes if the patient has atopic dermatitis). Your doctor, nurse or pharmacist will tell you how much cream to use.</li></ul><p><strong>Use on genital skin before injections of local anaesthetics</strong></p><ul><li>Lignox can be used in this way only by healthcare professionals on adults and adolescents over 12 years.</li><li>The usual dose is 1 g of cream (1 g to 2 g for female genital skin) for each area of skin that is 10 cm<sup>2</sup> (10 square centimetres) in size.</li><li>The cream is put on under a dressing. This is done for 15 minutes on male genital skin and for 60 minutes on female genital skin.</li></ul><p><strong>Use on the genitals before minor skin surgery (such as removal of warts)</strong></p><ul><li>Lignox can be used in this way only by healthcare professionals on adults and adolescents over 12 years.</li><li>The usual dose is 5 g to 10 g of cream for 10 minutes. A dressing is not used. The medical procedure should then start straight away.</li></ul><p><strong>Use on leg ulcers before cleaning or removal of damaged skin</strong></p><ul><li>Lignox can be used in this way in adults, but only under the supervision of a doctor or nurse.</li><li>The usual dose is 1 g to 2 g of cream for each area of skin that is 10 cm<sup>2</sup> up to a total of 10 g.</li><li>The cream is put on under an airtight dressing such as plastic wrap. This is done for 30 to 60 minutes before the ulcer is to be cleansed. Remove the cream with cotton gauze and start cleansing without delay.</li><li>Lignox can be used before cleansing of leg ulcers for up to 15 times over a period of 1 &ndash; 2 months.</li><li>The Lignox tube is intended for single use when used on leg ulcers: The tube with any remaining contents should be discarded after each occasion that a patient has been treated.</li></ul><p><strong>If you use more Lignox than you should</strong><br />If you use more Lignox than is described in this leaflet or more than your doctor, pharmacist or nurse has told you to, talk to one of them straight away, even if you do not feel any symptoms.</p><p>Symptoms of using too much Lignox are listed below. These symptoms are unlikely to happen if Lignox is used as recommended.</p><ul><li>Feeling light-headed or dizzy.</li><li>Tingling of the skin around the mouth and numbness of the tongue.</li><li>Abnormal taste.</li><li>Blurred vision.</li><li>Ringing in the ears.</li><li>There is also a risk of &lsquo;acute methaemoglobinaemia&rsquo; (a problem with blood pigment levels). This is more likely when certain medicines have been taken at the same time. If this happens, the skin becomes bluish-grey due to a lack of oxygen.</li></ul><p>In serious cases of overdose, symptoms may include fits, low blood pressure, slowed breathing, stopped breathing and altered heartbeat. These effects may be life-threatening.</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects although not everybody gets them.</p><p>Contact your doctor or pharmacist if any of the following side effects bother you or do not seem to go away. Tell your doctor about anything else that makes you feel unwell while you are using Lignox.</p><p>If you experience any of the following effects while you are using Lignox, stop using it and check with your doctor or pharmacist as soon as possible:</p><ul><li>Allergic reactions, which in rare cases may develop into anaphylactic shock (skin rash, swelling, fever, respiratory difficulties and fainting) during treatment of skin, genital mucosa or leg ulcers.</li><li>Methaemoglobinaemia (blood disorder), which in rare cases may develop during treatment of the skin, and may cause signs and symptoms of hypoxaemia (abnormally low level of oxygen in the blood). Methaemoglobinaemia is more frequently observed, often in connection with overdose, in newborn infants and infants aged 0 to 12 months.</li></ul><p>A mild reaction (paleness or redness of the skin, slight puffiness, initial burning or itching) may occur on the area on which Lignox is used. These are normal reactions to the cream and the anaesthetics and will disappear in a short while without any measures being needed.</p><p>If you experience any troublesome or unusual effects while you are using Lignox, stop using it and check with your doctor or pharmacist as soon as possible.</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><ul><li>Transient local skin reactions (paleness, redness, swelling) in the treated area during treatment of skin, genital mucosa or leg ulcers.</li><li>An initially mild sensation of burning, itching or warmth at the treated area during treatment of genital mucosa or leg ulcers.</li></ul><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><ul><li>An initially mild sensation of burning, itching or warmth at the treated area during treatment of the skin.</li><li>Numbness (tingling) in the treated area during treatment of genital mucosa.</li><li>Irritation of the treated skin during treatment of leg ulcers.</li></ul><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><ul><li>Small dot-shaped bleeding on the treated area (particularly on children with eczema after longer application times) during treatment of the skin.</li><li>Irritation of the eyes if Lignox accidentally comes into contact with them during treatment of the skin.</li></ul><p><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not store above 30&deg;C.<br />Do not freeze.<br />Do not use this medicine after the expiry date which is stated on the carton and tube after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>The active substances are lidocaine and prilocaine. Each gram of cream contains 25 mg of lidocaine and 25 mg of prilocaine.</li><li>The other ingredients are macrogolglycerol hydroxystearate, carbopol, sodium hydroxide and purified water.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lignox is a white shiny homogenous cream. Your cream will come in carton packs containing:
•	Single 5 g tube of cream; or
•	5 x 5 g tubes of cream with 5 dressings; or
•	Single 30 g tube of cream
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Saudi Pharmaceutical Industries<br />P.O. Box No.: 355127, Riyadh 11383<br />Kingdom of Saudi Arabia.<br />Tel: (+96611) 2650450, 2650354<br />Fax: (+96611) 2650383<br />Email: info@saudi-pharma.net</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي ليجنوكس على اثنتين من المواد الفعالة هما ليدوكايين وبريلوكايين. تنتمي هذه المواد إلى مجموعة من الأدوية تدعى المخدرات الموضعية.</p><p dir="RTL">يعمل ليجنوكس من خلال تخدير سطح الجلد لمدة قصيرة. حيث يوضع على الجلد قبل بعض الإجراءات الطبية. وهذا يساعد على إيقاف الألم على الجلد؛ ومع ذلك فقد يستمر لديك الشعور بالضغط واللمس.</p><p dir="RTL"><strong>البالغون والمراهقون والأطفال</strong><br />يمكن أن يستخدم لتخدير الجلد قبل:</p><ul dir="rtl"><li>إدخال إبرة (على سبيل المثال، في حال إعطائك حقنة أو إجراء اختبار للدم).</li><li>العمليات الجلدية الصغيرة.</li></ul><p dir="RTL"><strong>البالغون والمراهقون</strong><br />يمكن أن يستخدم أيضاً:</p><ul dir="rtl"><li>لتخدير الأعضاء التناسلية قبل:<ul><li>الحصول على حقنة.</li><li>الإجراءات الطبية مثل إزالة الثآليل.</li></ul></li></ul><p dir="RTL">ينبغي أن يقوم الطبيب أو الممرض بتطبيق ليجنوكس على الأعضاء التناسلية.</p><p dir="RTL"><strong>البالغون</strong><br />يمكن أن يستخدم أيضاً لتخدير الجلد قبل:</p><ul dir="rtl"><li>تنظيف أو إزالة الجلد التالف في حالة قرحات الساقين.</li></ul><p dir="RTL">في حالة استخدام المستحضر لأغراض أخرى غير التطبيق على الجلد السليم، فإنه ينبغي أن يستخدم فقط بعد توصية من الطبيب أو الممرض أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استخدام </strong><strong>ليجنوكس</strong></p><ul dir="rtl"><li>إذا كانت لديك حساسية تجاه ليدوكايين أو بريلوكايين أو المخدرات الموضعية الأخرى المماثلة لهما أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم 6).</li></ul><p dir="RTL"><strong>الاحتياطات عند استخدام ليجنوكس</strong><br />استشر طبيبك أو الصيدلي أو الممرض قبل استخدام ليجنوكس:</p><ul dir="rtl"><li>إذا كنت مصاباً أنت أو طفلك بمرض وراثي نادر يؤثر على الدم يدعى &quot;نقص إنزيم غلوكوز-6-فسفات ديهيدروجيناز&quot;.</li><li>إذا كنت تعاني أنت أو طفلك من مشكلة في مستويات الصباغ الدموي تدعى &quot;ميتهيموغلوبينية الدم (وجود الميتهيموغلوبين في الدم)&quot;.</li><li>لا تستخدم ليجنوكس على مناطق الجلد المصابة بالطفح أو الجروح أو الخدوش (السحجات) أو الجروح المفتوحة الأخرى، باستثناء قرحة الساق. إذا وجدت أي من هذه الحالات، فقم باستشارة طبيبك أو الصيدلي أو الممرض قبل استخدام الكريم.</li><li>إذا كنت تعاني أنت أو طفلك من حالة حكة جلدية تدعى &quot;التهاب الجلد التأتبي&quot;، فقد يكون التطبيق لمدة أقصر كافياً في هذه الحالة. قد يؤدي التطبيق لمدة أطول من 30 دقيقة إلى زيادة حدوث التفاعلات الجلدية الموضعية (راجع أيضاً القسم 4 &quot;الأعراض الجانبية المحتملة&quot;).</li><li>إذا كنت تتناول مستحضرات خاصة باضطرابات نظم القلب (الأدوية المضادة لاضطرابات النظم من الصنف الثالث مثل أميودارون). سيقوم طبيبك في تلك الحالة بمراقبة وظائف القلب عندك.</li></ul><p dir="RTL">نظراً لوجود احتمالية تعزيز الامتصاص على الجلد الذي تم حلق الشعر منه حديثاً، فإنه من الضروري اتباع التوصيات الخاصة بالجرعة ومساحة الجلد ومدة التطبيق.</p><p dir="RTL">تجنب دخول ليجنوكس إلى العينين، حيث إنه قد يسبب تهيجاً. إذا دخل ليجنوكس إلى عينك بشكل عرضي، فينبغي عليك غسلها فوراً بشكل جيد بماء فاتر أو محلول الملح (محلول كلوريد الصوديوم). كن حذراً لتجنب دخول أي شيء في عينيك حتى تستعيد الشعور بهما.</p><p dir="RTL">يجب ألا يتم تطبيق ليجنوكس على غشاء الطبل التالف.</p><p dir="RTL">عندما تستخدم ليجنوكس قبل أن تحصل على لقاح حي (مثل لقاح السل)، فينبغي عليك الرجوع إلى طبيبك أو الممرض بعد الوقت المطلوب منك لمتابعة نتيجة التلقيح (التطعيم).</p><p dir="RTL"><strong>الأطفال والمراهقون</strong><br />عند الرضع/الرضع حديثي الولادة بعمر أقل من 3 أشهر، تمت بشكل شائع ملاحظة زيادة عابرة غير مهمة سريرياً في مستويات صباغ الدم &quot;ميتهيموغلوبينية الدم&quot; حتى 12 ساعة بعد تطبيق ليجنوكس.</p><p dir="RTL">لا يمكن من خلال الدراسات السريرية إثبات فعالية ليجنوكس عند سحب الدم من عقب (كعب) الرضع حديثي الولادة أو لتوفير التسكين الكافي للألم عند الختان.</p><p dir="RTL">ينبغي ألا يتم تطبيق ليجنوكس على جلد الأعضاء التناسلية (مثل القضيب) ومخاطية الأعضاء التناسلية (في المهبل مثلاً) للأطفال (بعمر أقل من 12 عاماً) بسبب عدم كفاية البيانات حول امتصاص المواد الفعالة.</p><p dir="RTL">ينبغي عدم استخدام ليجنوكس في الأطفال بعمر أقل من 12 شهراً الذين تتم معالجتهم في الوقت نفسه بأدوية أخرى تؤثر على مستويات صباغ الدم &quot; ميتهيموغلوبينية الدم&quot; (مثل السلفوناميدات، راجع أيضاً القسم 2 &quot;التداخلات الدوائية من إعطاء ليجنوكس مع أي أدوية أخرى&quot;).</p><p dir="RTL">ينبغي عدم استخدام ليجنوكس للخدج حديثي الولادة.</p><p dir="RTL"><strong>التداخلات الدوائية من إعطاء ليجنوكس مع أي أدوية أخرى</strong><br />أخبر طبيبك أو الصيدلي إذا كنت تستخدم/تتناول، أو قد استخدمت/تناولت مؤخراً أو قد تستخدم/تتناول أي أدوية أخرى. هذا يشمل الأدوية التي حصلت عليها دون وصفة طبية وكذلك الأدوية العشبية. وذلك لأن ليجنوكس يمكن أن يؤثر على الطريقة التي تعمل بها بعض الأدوية وأن بعض الأدوية يمكن أن تؤثر على ليجنوكس.</p><p dir="RTL">بشكل خاص، أخبر طبيبك أو الصيدلي إذا استخدمت مؤخراً أنت أو طفلك أو أعطيت لكما أي من الأدوية التالية:</p><ul dir="rtl"><li>أدوية تستخدم لمعالجة العدوى، تدعى &quot;السلفوناميدات&quot; ونتروفورانتوين.</li><li>أدوية تستخدم لمعالجة الصرع، تدعى فينيتوين وفينوباربيتال.</li><li>مخدرات موضعية أخرى.</li><li>أدوية لمعالجة عدم انتظام ضربات القلب، مثل أميودارون.</li><li>سيميتيدين أو حاصرات مستقبلات بيتا، التي قد تسبب زيادة في مستويات الليدوكايين في الدم. ليست لهذه التداخلات أهمية سريرية عند المعالجة قصير الأمد بليجنوكس بالجرعات الموصى بها.</li></ul><p dir="RTL"><strong>الحمل والرضاعة والخصوبة</strong><br />إذا كنت حاملاً أو مرضعة أو تعتقدين بأنك حامل أو تخططين للحمل، فاستشيري الطبيب أو الصيدلي قبل استخدام هذا الدواء.</p><p dir="RTL">من غير المحتمل أن يؤدي الاستخدام المتقطع لليجنوكس أثناء الحمل إلى أية أعراض جانبية على الجنين.</p><p dir="RTL">تنتقل المواد الفعالة في ليجنوكس (ليدوكايين وبريلوكايين) إلى حليب الأم. وعلى أية حال فإن الكمية قليلة جداً بحيث إنها لا تشكل خطراً على الرضيع بشكل عام.</p><p dir="RTL">أظهرت الدراسات التي أجريت على الحيوانات عدم حدوث ضعف في خصوبة الذكور أو الإناث.</p><p dir="RTL"><strong>تأثير ليجنوكس على القيادة واستخدام الآلات</strong><br />إن ليجنوكس ليس له تأثير أو أن تأثيره ضئيل على القدرة على القيادة واستخدام الآلات عندما يستخدم بالجرعات الموصى بها.</p><p dir="RTL"><strong>ليجنوكس يحتوي على ماكروغول غليسيرول هيدروكسي ستيارات</strong><br />قد يسبب ماكروغول غليسيرول هيدروكسي ستيارات تفاعلات جلدية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائماً استخدم ليجنوكس تماماً كما هو موضح في هذه النشرة أو كما أخبرك به الطبيب أو الصيدلي أو الممرض. إن لم تكن متأكداً من كيفية الاستخدام ارجع إلى طبيبك أو الصيدلي.</p><p dir="RTL">يتوفر هذا المنتج بعبوات ذات أحجام مختلفة. سيتم تزويدك بالعبوة ذات الحجم المناسب لغرض استخدامك للدواء.</p><p dir="RTL"><strong>استخدام ليجنوكس</strong></p><ul dir="rtl"><li>يعتمد مكان تطبيق الكريم، والكمية التي ستستخدمها والمدة اللازمة لتركه على الجلد على الغرض من استخدامه. يعادل نصف أنبوب (عبوة 5 غ) حوالي 2 غ من ليجنوكس. يعادل غرام واحد من ليجنوكس عند ضغط أنبوب (عبوة 30 غ) حوالي 3.5 سم.</li><li>ينبغي استخدام ليجنوكس على الأعضاء التناسلية من قبل الطبيب أو الممرض فقط.</li><li>عند استخدام ليجنوكس على قرحات الساق، فينبغي أن يقوم طبيب أو ممرض بالإشراف على استخدامه.</li></ul><p dir="RTL"><strong>لا تستخدم ليجنوكس على المناطق التالية:</strong></p><ul dir="rtl"><li>الجروح والخدوش (السحجات) باستثناء قرحات الساق.</li><li>عند وجود طفح جلدي أو إكزيمة.</li><li>داخل العينين أو قريباً منهما.</li><li>داخل الأنف أو الأذن أو الفم.</li><li>المجرى الخلفي (الشرج).</li><li>الأعضاء التناسلية عند الأطفال.</li></ul><p dir="RTL">ينبغي على الأشخاص الذين يقومون بتطبيق أو إزالة الكريم بشكل متكرر التأكد من تجنب التماس لمنع تطور فرط التحسس عندهم.</p><p dir="RTL">يتم ثقب الحاجز الواقي للأنبوب عن طريق الغطاء.</p><p dir="RTL"><strong>الاستخدام على الجلد قبل الإجراءات البسيطة (مثل حقن إبرة أو العمليات الجلدية الصغيرة):</strong></p><ul dir="rtl"><li>يوضع الكريم على الجلد بشكل طبقة سميكة. اتبع التعليمات الموضحة في النشرة أو تعليمات أخصائي الرعاية الصحية. سيتعين على أخصائي الرعاية الصحية القيام بتطبيق الكريم في بعض الحالات.</li><li>تتم تغطية الكريم بعد ذلك بضماد [غطاء بلاستيكي]. ينزع مباشرة قبل بدء الإجراء. إذا كنت تقوم بتطبيق الكريم بنفسك، فتأكد بأن الطبيب أو الصيدلي أو الممرض قد قام بإعطائك ضماداً.</li><li>الجرعة الاعتيادية للبالغين والمراهقين بعمر أكبر من 12 عاماً هو 2 غ.</li><li>بالنسبة للبالغين والمراهقين بعمر أكبر من 12 عاماً، يتم وضع الكريم لمدة لا تقل عن 60 دقيقة قبل الإجراء (إلا إذا كان الكريم يستخدم على الأعضاء التناسلية). وعلى أية حال، فلا تقم بوضع الكريم لمدة أكثر من 5 ساعات قبل الإجراء.</li></ul><p dir="RTL"><strong>الأطفال<br />الاستخدام على الجلد قبل الإجراءات البسيطة (مثل حقن إبرة أو العمليات الجلدية الصغيرة). </strong>مدة التطبيق:<strong> </strong>حوالي<strong> ساعة واحدة.</strong></p><p dir="RTL"><strong><em>الرضع حديثو الولادة والرضع 0 &ndash; شهرين:</em></strong><em> </em>حتى 1 غ من الكريم على مساحة من الجلد لا تزيد عن 10 سم<sup>2</sup>. مدة التطبيق: <strong>ليست أكثر من</strong> <strong>ساعة واحدة. ينبغي إعطاء جرعة وحيدة فقط خلال مدة 24 ساعة.</strong></p><p dir="RTL"><strong><em>الرضع بعمر 3 &ndash; 11 شهراً:</em></strong> حتى 2 غ من الكريم على مساحة إجمالية من الجلد لا تزيد عن 20 سم<sup>2</sup>. مدة التطبيق: حوالي<strong> ساعة واحدة.</strong></p><p dir="RTL"><strong><em>الأطفال بعمر 1 &ndash; 5 أعوام:</em></strong> حتى 10 غ من الكريم على مساحة إجمالية من الجلد لا تزيد عن 100 سم<sup>2</sup>. مدة التطبيق: حوالي <strong>ساعة واحدة،</strong> بحد أقصى 5 ساعات.</p><p dir="RTL"><strong><em>الأطفال بعمر 6 &ndash; 11 عاماً:</em></strong> حتى 20 غ من الكريم على مساحة إجمالية من الجلد لا تزيد عن 200 سم<sup>2</sup>. مدة التطبيق: حوالي <strong>ساعة واحدة، </strong>بحد أقصى 5 ساعات.</p><p dir="RTL">يمكن استخدام جرعتين كحد أقصى بفاصل لا يقل عن 12 ساعة للأطفال بعمر أكبر من 3 أشهر خلال مدة 24 ساعة.</p><p dir="RTL">يمكن استخدام ليجنوكس للأطفال المصابين بحالة جلدية تدعى &quot;التهاب الجلد التأتبي&quot; ولكن مدة التطبيق في هذه الحالة لا تزيد عن 30 دقيقة.</p><p dir="RTL">عندما تقوم بتطبيق الكريم، فمن المهم أن تقوم باتباع التعليمات التالية بالضبط:</p><ol dir="rtl"><li>قم بضغط الكريم على شكل كومة في المكان الذي تريده على جلدك (مثلاً في مكان إدخال الإبرة). يعادل نصف أنبوب (عبوة 5 غ) حوالي 2 غ من ليجنوكس. يعادل غرام واحد من ليجنوكس عند ضغط أنبوب (عبوة 30 غ) حوالي 3.5 سم. لا تقم بفرك الكريم.<br /><img alt="" width="116" height="128" src="data:image/png;base64,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" /></li><li>اقشر الطبقة الورقية من &quot;مركز القطع&quot; للجانب غير اللاصق من الضماد (تاركاً إطاراً من الورق).<br /><img alt="" width="128" height="128" src="data:image/png;base64,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" /></li><li>أزل غطاء الجانب اللاصق من الضماد.<br /><img alt="" width="128" height="128" src="data:image/png;base64,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" /></li><li>قم بوضع الضماد بحذر فوق كومة الكريم. لا تقم بتوزيع الكريم تحت الضغط.<br /><img alt="" width="128" height="125" src="data:image/png;base64,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" /></li><li>قم بإزالة الدعامة الورقية. قم بفرد حواف الضمادة بحذر. ثم اتركها في المكان لمدة لا تقل عن 60 دقيقة إذا لم يحدث ضرر على الجلد. ينبغي ألا يترك الكريم في المكان لمدة تزيد عن 60 دقيقة عند الأطفال بعمر أقل من 3 أشهر أو تزيد عن 30 دقيقة عند الأطفال الذين يعانون من حالة من حكة جلدية تدعى &quot;التهاب الجلد التأتبي&quot;. إذا كان الكريم يستخدم على الأعضاء التناسلية أو على القرحات، فقد تستخدم مدد تطبيق أقصر كما هو موضح أدناه.<br /><img alt="" width="128" height="124" src="data:image/png;base64,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" /></li><li>سيقوم طبيبك أو الممرض بنزع الضماد وإزالة الكريم تماماً قبل أن يقوموا بالإجراء الطبي (تماماً قبل إدخال الإبرة على سبيل المثال).<br /><img alt="" width="128" height="117" src="data:image/png;base64,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" /></li></ol><p dir="RTL"><strong>الاستخدام على مساحات أكبر من الجلد الذي تم حلقه حديثاً قبل الإجراءات في العيادات الخارجية (مثل تقنيات إزالة الشعر):</strong><br />اتبع تعليمات أخصائي الرعاية الصحية.</p><p dir="RTL">الجرعة الاعتيادية هي 1 غ من الكريم لكل مساحة من الجلد تعادل 10 سم<sup>2</sup>، تطبق لمدة 1 إلى 5 ساعات تحت ضماد. ينبغي ألا يستخدم ليجنوكس على مساحة من الجلد الذي تم حلقه حديثاً بحيث تكون أكبر من 600 سم<sup>2</sup> (مثلاً، 30 سم &times; 20 سم). الجرعة القصوى هي 60 غ.</p><p dir="RTL"><strong>الاستخدام على الجلد قبل الإجراءات داخل المستشفى (مثل ترقيع الجلد المنقسم) التي تستدعي تخديراً جلدياً أعمق:</strong></p><ul dir="rtl"><li>يمكن أن يستخدم ليجنوكس بهذه الطريقة للبالغين والمراهقين بعمر أكبر من 12 عاماً، ولكن فقط تحت إشراف طبيب أو ممرض.</li><li>الجرعة الاعتيادية 1.5 غ إلى 2 غ من الكريم لكل مساحة من الجلد تعادل 10 سم<sup>2</sup>.</li><li>يوضع الكريم تحت ضماد لمدة 2 إلى 5 ساعات.</li></ul><p dir="RTL"><strong>الاستخدام على الجلد قبل إزالة البقع الشبيهة بالثآليل &quot;الرخويات&quot;</strong></p><ul dir="rtl"><li>يمكن أن يستخدم ليجنوكس للأطفال والمراهقين الذين يعانون من حالة تدعى &quot;التهاب الجلد التأتبي&quot;.</li><li>تعتمد الجرعة الاعتيادية على عمر الطفل وتستخدم لمدة 30 إلى 60 دقيقة (30 دقيقة إذا كان المريض يعاني من التهاب الجلد التأتبي). سيخبرك طبيبك أو الممرض أو الصيدلي عن الكمية التي يجب أن تستخدمها.</li></ul><p dir="RTL"><strong>الاستخدام على جلد المناطق التناسلية قبل حقن المخدرات الموضعية</strong></p><ul dir="rtl"><li>يمكن أن يستخدم ليجنوكس بهذه الطريقة فقط من قبل أخصائيي الرعاية الصحية للبالغين والمراهقين بعمر أكبر من 12 عاماً.</li><li>الجرعة الاعتيادية 1 غ من الكريم (1 غ إلى 2 غ في حالة جلد الأعضاء التناسلية عند الإناث) لكل مساحة من الجلد تعادل 10 سم<sup>2</sup>.</li><li>يوضع الكريم تحت ضماد. يتم ذلك لمدة 15 دقيقة على جلد الأعضاء التناسلية للذكور ولمدة 60 دقيقة على جلد الأعضاء التناسلية للإناث.</li></ul><p dir="RTL"><strong>الاستخدام على الأعضاء التناسلية قبل الجراحات الجلدية البسيطة (مثل إزالة الثآليل)</strong></p><ul dir="rtl"><li>يمكن أن يستخدم ليجنوكس بهذه الطريقة من قبل أخصائيي الرعاية الصحية فقط للبالغين والمراهقين بعمر أكبر من 12 عاماً.</li><li>الجرعة الاعتيادية 5 غ إلى 10 غ من الكريم لمدة 10 دقائق. لا يستخدم ضماد. ينبغي أن يبدأ الإجراء الطبي بعد ذلك على الفور.</li></ul><p dir="RTL"><strong>&nbsp;الاستخدام على قرحات الساق قبل التنظيف أو إزالة الجلد التالف</strong></p><ul dir="rtl"><li>يمكن أن يستخدم ليجنوكس بهذه الطريقة عند البالغين، ولكن فقط تحت إشراف طبيب أو ممرض.</li><li>الجرعة الاعتيادية 1 غ إلى 2 غ من الكريم لكل مساحة من الجلد تعادل 10 سم<sup>2</sup> وحتى ما مجموعه 10 غ.</li><li>يوضع الكريم تحت ضماد محكم مثل غطاء بلاستيكي. يتم ذلك لمدة 30 إلى 60 دقيقة قبل تنظيف القرحة. قم بإزالة الكريم بشاش قطني وابدأ التنظيف دون تأخير.</li><li>يمكن أن يستخدم ليجنوكس قبل تنظيف قرحات الساق حتى 15 مرة خلال فترة شهر واحد إلى شهرين.</li><li>أنبوب ليجنوكس معد للاستخدام مرة واحدة عندما يستخدم على قرحات الساق: يجب التخلص من الأنبوب وأية بقايا من محتوياته بعد كل مرة تتم فيها معالجة المريض.</li></ul><p dir="RTL"><strong>إذا استخدمت ليجنوكس أكثر من اللازم</strong><br />إذا استخدمت ليجنوكس أكثر مما هو موضح في هذه النشرة أو أكثر مما أخبرك به طبيبك أو الصيدلي أو الممرض، فأخبر أحداً منهم على الفور، حتى وإن لم تشعر بأية أعراض.</p><p dir="RTL">أعراض استخدام كمية أكثر من اللازم من ليجنوكس مدرجة أدناه. من غير المحتمل حدوث هذه الأعراض إذا استخدم ليجنوكس حسب ما هو موصى به.</p><ul dir="rtl"><li>الشعور بالدوخة.</li><li>نخز في الجلد حول الفم وتنميل (اخدرار) اللسان.</li><li>طعم غير طبيعي.</li><li>عدم وضوح الرؤية (تغيم الرؤية).</li><li>طنين في الأذنين.</li><li>يوجد أيضاً خطر لحدوث &quot;ميتهيموغلوبينية الدم الحادة&quot; (مشكلة في مستويات صباغ الدم). وحدوثها أكثر احتمالاً عند استخدام بعض الأدوية في الوقت نفسه. إذا حدث هذا، يصبح الجلد رمادياً مزرقاً بسبب نقص الأكسجين.</li></ul><p dir="RTL">في الحالات الخطيرة للجرعة الزائدة، قد تشتمل الأعراض على نوبات وانخفاض ضغط الدم وبطء التنفس وتوقف التنفس وتغير في ضربات القلب. قد تكون هذه التأثيرات مهددة للحياة.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال في كل الأدوية، هذا الدواء يمكن أن يتسبب بأعراض جانبية، بالرغم من أنها قد لا تحدث للجميع.</p><p dir="RTL">اتصل بطبيبك أو الصيدلي إذا أزعجتك أي من الأعراض الجانبية التالية أو بدت أنها لا تزول. أخبر طبيبك حول أي شيء آخر يجعلك تشعر بالتوعك أثناء استخدامك لليجنوكس.</p><p dir="RTL">إذا عانيت من أي من الأعراض التالية أثناء استخدامك لليجنوكس، فأوقف استخدامه وراجع طبيبك أو الصيدلي في أقرب وقت:</p><ul dir="rtl"><li>تفاعلات تحسسية، قد تتطور في حالات نادرة إلى صدمة تأقية (تحسسية) (طفح جلدي، تورم، حمى، صعوبات في التنفس، إغماء) أثناء معالجة الجلد أو مخاطية الأعضاء التناسلية أو قرحات الساق.</li><li>ميتهيموغلوبينية الدم (اضراب دموي)، قد تتطور في حالات نادرة أثناء معالجة الجلد، وقد تسبب علامات وأعراض نقص الأكسجين في الدم (انخفاض غير طبيعي لمستوى الأكسجين في الدم). تلاحظ ميتهيموغلوبينية الدم بشكل أكثر تكراراً، وترتبط غالباً بالجرعة الزائدة، عند الرضع حديثي الولادة والرضع بعمر 0 إلى 12 شهراً.</li></ul><p dir="RTL">قد يحدث تفاعل خفيف (شحوب أو احمرار الجلد، انتفاخ خفيف، حرق أو حكة في البداية) في المنطقة التي استخدم عليها ليجنوكس. وهذه ردود فعل طبيعية تجاه الكريم والمخدرات وتتلاشى خلال فترة قصيرة دون الحاجة إلى اتخاذ أية تدابير.</p><p dir="RTL">إذا عانيت من أية أعراض مزعجة أو غير اعتيادية أثناء استخدامك لليجنوكس، فأوقف استخدامه وراجع طبيبك أو الصيدلي في أقرب وقت.</p><p dir="RTL"><strong>شائعة </strong>(قد تؤثر على 1 من بين 10 أشخاص)</p><ul dir="rtl"><li>تفاعلات جلدية موضعية عابرة (شحوب، احمرار، تورم) في المنطقة المعالجة أثناء معالجة الجلد أو مخاطية الأعضاء التناسلية أو قرحات الساق.</li><li>إحساس خفيف في البداية بالحرق أو الحكة أو السخونة في المنطقة المعالجة أثناء معالجة مخاطية الأعضاء التناسلية أو قرحات الساق.</li></ul><p dir="RTL"><strong>غير شائعة </strong>(قد تؤثر على 1 من بين 100 شخص)</p><ul dir="rtl"><li>إحساس خفيف في البداية بالحرق أو الحكة أو السخونة في المنطقة المعالجة أثناء معالجة الجلد.</li><li>تنميل (نخز) في المنطقة المعالجة أثناء معالجة مخاطية الأعضاء التناسلية.</li><li>تهيج في الجلد المعالج أثناء معالجة قرحات الساق.</li></ul><p dir="RTL"><strong>نادرة </strong>(قد تؤثر على 1 من بين 1000 شخص)</p><ul dir="rtl"><li>نزف صغير على شكل نقطة في المنطقة المعالجة (وبخاصة عند الأطفال المصابين بالإكزيمة بعد مدد تطبيق أطول) أثناء معالجة الجلد.</li><li>تهيج في العينين إذا دخل فيهما ليجنوكس بشكل عرضي أثناء معالجة الجلد.</li></ul><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong><br />إن كان لديك أعراض جانبية، أبلغ الطبيب أو الصيدلي أو الممرض، هذا يشمل أية أعراض جانبية غير مذكورة في هذه النشرة. من خلال الإبلاغ عن الأعراض الجانبية، فإنك تساعد على تقديم معلومات أكثر حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيداً عن متناول ومرأى الأطفال.<br />يخزن عند حرارة لا تزيد عن 30&deg;م.<br />لا يجمد.<br />لا تستخدم هذا الدواء بعد انتهاء تاريخ الصلاحية المدون على العبوة والأنبوب. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.<br />لا تتخلص من الدواء عن طريق رميه في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الدواء إذا لم تعد بحاجته. هذه الإجراءات ستساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>المواد الفعالة هي ليدوكايين وبريلوكايين. يحتوي كل 1 غ من الكريم على 25 ملغ من ليدوكايين و25 ملغ بريلوكايين.</li><li>المكونات الأخرى هي ماكروغول غليسيرول هيدروكسي ستيارات، كاربوبول، هيدروكسيد الصوديوم، ماء منقى.</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ليجنوكس عبارة عن كريم أبيض لامع متجانس. يتوفر الكريم في عبوات كرتونية تحتوي على:</p><ul dir="rtl"><li>أنبوب واحد يحتوي على 5 غ من الكريم؛ أو</li><li>5 أنابيب يحتوي كل منها على 5 غ من الكريم مع 5 ضمادات؛ أو</li><li>أنبوب واحد يحتوي على 30 غ من الكريم</li></ul><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة السعودية للصناعات الصيدلانية<br />صندوق بريد رقم: 355127، الرياض 11383<br />المملكة العربية السعودية.<br />هاتف: 2650354، 2650450 (96611+)<br />فاكس: 2650383 (96611+)<br />بريد إلكتروني: info@saudi-pharma.net</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lignox 5% Cream.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine 2.5% w/w (25 mg/g)
Prilocaine 2.5% w/w (25 mg/g)
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cream.
A white shiny homogenous cream.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lignox is indicated for:</p><ul><li>Topical anaesthesia of the skin in connection with:<ul><li>needle insertion, e.g., intravenous catheters or blood sampling;</li><li>superficial surgical procedures;</li></ul></li></ul><p>in adults and in the paediatric population.</p><ul><li>Topical anaesthesia of the genital mucosa, e.g., prior to superficial surgical procedures or infiltration anaesthesia; in adults and adolescents &ge; 12 years.</li><li>Topical anaesthesia of leg ulcers to facilitate mechanical cleansing/debridement in adults only.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Administration of Lignox on genital mucosa, genital skin or leg ulcers should only be performed by or under the supervision of a healthcare professional.</p><p><u>Posology</u><br /><em>Adults and adolescents</em><br />The details of the Indications or Procedures for use, with Dosage and Application Time are provided in Tables 1 and 2.</p><p>For further guidance on the appropriate use of the product in such procedures, please refer to <em>Method of administration.</em><br /><strong>Table 1 Adults and adolescents 12 years of age and above</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Indication/Procedure</strong></p></td><td style="vertical-align:top"><p><strong>Dosage and Application Time</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin</strong></p></td></tr><tr><td style="vertical-align:top"><p>Minor procedures, e.g., needle insertion and surgical treatment of localised lesions.</p></td><td style="vertical-align:top"><p>2 g (approx. half a 5 g tube) or approx. 1.5 g/10 cm<sup>2</sup> for 1 to 5 hours<sup>1)</sup>.</p></td></tr><tr><td style="vertical-align:top"><p>Dermal procedures on newly shaven skin of large body areas, e.g., laser hair removal (self-application by patient)</p></td><td style="vertical-align:top"><p>Maximum recommended dose: 60 g.<br />Maximum recommended treated area; 600 cm<sup>2</sup> for a minimum of 1 hour, maximum 5 hours<sup>1)</sup>.</p></td></tr><tr><td style="vertical-align:top"><p>Dermal surgical procedures on larger areas in a hospital setting, e.g., split-skin grafting.</p></td><td style="vertical-align:top"><p>Approx. 1.5 &ndash; 2 g/10 cm<sup>2</sup> for 2 to 5 hours<sup>1)</sup>.</p></td></tr><tr><td style="vertical-align:top"><p>Skin of male genital organs</p><p>Prior to injection of local anaesthetics</p><p>Skin of female genital organs</p><p>Prior to injection of local anaesthetics<sup>2)</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1 g/10 cm<sup>2</sup> for 15 minutes</p><p>&nbsp;</p><p>1 &ndash; 2 g/10 cm<sup>2</sup> for 60 minutes</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Genital mucosa</strong></p></td></tr><tr><td style="vertical-align:top"><p>Surgical treatment of localised lesions, e.g., removal of genital warts (condylomata acuminata) and prior to injection of local anaesthetics</p></td><td style="vertical-align:top"><p>Approx. 5 &ndash; 10 g of cream for 5 &ndash; 10 minutes<sup>1) 3) 4)</sup>.</p></td></tr><tr><td style="vertical-align:top"><p>Prior to cervical curettage</p></td><td style="vertical-align:top"><p>10 g of cream should be administered in the lateral vaginal fornices for 10 minutes.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Leg ulcer(s)</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Adults only</u><br />Mechanical cleansing/debridement</p></td><td style="vertical-align:top"><p>Approx 1 &ndash; 2 g/10 cm<sup>2</sup> up to a total of 10 g to the leg ulcer(s)<sup>3) 5)</sup>.</p><p>Application time: 30 &ndash; 60 minutes.</p></td></tr></tbody></table><p><sup>1</sup> After a longer application time anaesthesia decreases.<br /><sup>2</sup> On female genital skin, Lignox alone applied for 60 or 90 minutes does not provide sufficient anaesthesia for thermocautery or diathermy of genital warts.<br /><sup>3</sup> Plasma concentrations have not been determined in patients treated with doses of &gt;10 g (see also section 5.2).<br /><sup>4</sup> In adolescents weighing less than 20 kg the maximum dose of Lignox on genital mucosa should be proportionally reduced.<br /><sup>5</sup> Lignox has been used for the treatment of leg ulcers up to 15 times over a period of 1 to 2 months without loss of efficacy or increased number or severity of adverse events.</p><p><em>Paediatric population</em><br /><strong>Table 2 Paediatric patients 0 &ndash; 11 years of age</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Age group</strong></p></td><td><p><strong>Procedure</strong></p></td><td><p><strong>Dosage and Application time</strong></p></td></tr><tr><td><p>&nbsp;</p></td><td><p>Minor procedures, e.g., needle insertion and surgical treatment of localised lesions.</p></td><td><p>&nbsp;</p></td></tr><tr><td><p>Newborn infants and infants 0 &ndash; 2 months<sup>1)2)3)</sup></p></td><td><p>&nbsp;</p></td><td><p>Up to 1 g and 10 cm<sup>2</sup> for one hour<sup>4)</sup></p></td></tr><tr><td><p>Infants 3 &ndash; 11 months<sup>1) 2)</sup></p></td><td><p>&nbsp;</p></td><td><p>Up to 2 g and 20 cm<sup>2</sup> for one hour<sup>5)</sup></p></td></tr><tr><td><p>Toddlers and children 1 &ndash; 5 years</p></td><td><p>&nbsp;</p></td><td><p>Up to 10 g and 100 cm<sup>2</sup> for 1 &ndash; 5 hours<sup>6)</sup></p></td></tr><tr><td><p>Children 6 &ndash; 11 years</p></td><td><p>&nbsp;</p></td><td><p>Up to 20 g and 200 cm<sup>2</sup> for 1 &ndash; 5 hours<sup>6)</sup></p></td></tr><tr><td><p>Paediatric patients with atopic dermatitis</p></td><td><p>Prior to removal of mollusca</p></td><td><p>Application time: 30 minutes</p></td></tr></tbody></table><p><sup>1</sup> In term newborn infants and infants below 3 months, only one single dose should be applied in any 24-hour period. For children aged 3 months and above, a maximum of 2 doses, separated by at least 12 hours can be given within any 24-hour period, see sections 4.4 and 4.8.<br /><sup>2</sup> Lignox should not be used in infants up to 12 months of age receiving treatment with methaemoglobin-inducing agents, because of safety concerns, see sections 4.4 and 4.8.<br /><sup>3</sup> Lignox should not be used at less than 37 weeks gestational age, because of safety concerns, see section 4.4.<br /><sup>4</sup> Application for &gt; 1 hour has not been documented.<br /><sup>5</sup> No clinically significant increase in methaemoglobin levels has been observed after an application time of up to 4 hours on 16 cm<sup>2</sup>.<br /><sup>6</sup> After longer application time anaesthesia decreases.</p><p>Safety and efficacy for the use of Lignox on genital skin and genital mucosa have not been established in children younger than 12 years.</p><p>Available paediatric data do not demonstrate adequate efficacy for circumcision.</p><p><em>Elderly</em><br />No dose reduction is necessary in elderly patients (see sections 5.1 and 5.2).</p><p><em>Hepatic impairment</em><br />A reduction of a single dose is not necessary in patients with impaired hepatic function (see section 5.2).</p><p><em>Renal impairment</em><br />A dose reduction is not necessary among patients with restricted renal function.</p><p><u>Method of administration</u><br />Cutaneous use</p><p>The protective membrane of the tube is perforated by applying the cap.</p><p>One gram of Lignox pressed out of a tube of 30 g is approximately 3.5 cm. If high levels of accuracy in dosing are required to prevent overdose (i.e., at doses approaching the maximum in newborn infants or if two applications may be required in a 24-hour period), a syringe can be used where 1 ml = 1 g.</p><p>A thick layer of Lignox should be applied to the skin, including genital skin, under an occlusive dressing. For application to larger areas, such as split-skin grafting, an elastic bandage should be applied on top of the occlusive dressing to give an even distribution of cream and protect the area. In the presence of atopic dermatitis, the application time should be reduced.</p><p>For procedures related to genital mucosa, no occlusive dressing is required. The procedure should be commenced immediately after removal of the cream.</p><p>For procedures related to leg ulcers, a thick layer of Lignox should be applied under an occlusive dressing. Cleansing should start without delay after removal of the cream.</p><p>The Lignox tube is intended for single use when used on leg ulcers: The tube with any remaining contents should be discarded after each occasion that a patient has been treated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to lidocaine and/or prilocaine or local anaesthetics of the amide type or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients with defective glucose-6-phosphate dehydrogenase, hereditary or idiopathic methaemoglobinaemia are more susceptible to active-substance-induced signs of methaemoglobinaemia. In glucose-6-phosphate dehydrogenase deficient patients the antidote methylene blue is ineffective at methaemoglobin reduction, and is capable of oxidizing haemoglobin itself, and therefore methylene blue therapy cannot be given.</p><p>Due to insufficient data on absorption, Lignox should not be applied to open wounds (excluding leg ulcers).</p><p>Due to the potentially enhanced absorption on newly shaven skin, it is important to adhere to the recommended dosage, area and time of application (see section 4.2).</p><p>Care should be taken when applying Lignox to patients with atopic dermatitis. A shorter application time, 15 &ndash; 30 minutes, may be sufficient (see section 5.1). Application times of longer than 30 minutes in patients with atopic dermatitis may result in an increased incidence of local vascular reactions, particularly application site redness and in some cases petechia and purpura (see section 4.8). Prior to removal of mollusca in children with atopic dermatitis it is recommended to apply cream for 30 minutes.</p><p>When applied in the vicinity of the eyes, Lignox should be used with particular care since it may cause eye irritation. Also, the loss of protective reflexes may allow corneal irritation and potential abrasion. If eye contact occurs, the eye should immediately be rinsed with water or sodium chloride solution and protected until sensation returns.</p><p>Lignox should not be applied to an impaired tympanic membrane. Tests on laboratory animals have shown that Lignox has an ototoxic effect when instilled into the middle ear. Animals with an intact tympanic membrane, however, show no abnormality when exposed to Lignox in the external auditory canal.</p><p>Patients treated with anti-arrhythmics of class III (e.g., amiodarone) should be carefully monitored and ECG monitoring considered, as cardiac effects may be additive.</p><p>Lidocaine and prilocaine have bacteriocidal and antiviral properties in concentrations above 0.5 &ndash; 2%. For this reason, although one clinical study suggests that the immunisation response, as assessed by local wheal formation, is not affected when Lignox is used prior to BCG vaccination, the results of intracutaneous injections of live vaccines should be monitored.</p><p>Lignox contains macrogolglycerol hydroxystearate, which may cause skin reactions.</p><p><em>Paediatric population</em><br />Studies have been unable to demonstrate the efficacy of Lignox for heel lancing in newborn infants.</p><p>In newborn infants/infants younger than 3 months a transient, clinically insignificant increase in methaemoglobin levels is commonly observed up to 12 hours after an application of Lignox within the recommended dosing.</p><p>If the recommended dose is exceeded the patient should be monitored for system adverse reactions secondary to methaemoglobinaemia (see sections 4.2, 4.8 and 4.9).</p><p>Lignox should not be used</p><ul><li>in newborn infants/infants up to 12 months of age receiving concomitant treatment with methaemoglobin-inducing agents.</li><li>in preterm newborn infants with a gestational age less than 37 weeks as they are at risk of developing increased methaemoglobin levels.</li></ul><p>Safety and efficacy for the use of Lignox on genital skin and genital mucosa have not been established in children younger than 12 years.</p><p>Available paediatric data do not demonstrate adequate efficacy for circumcision.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prilocaine in high doses may cause an increase in methaemoglobin levels particularly in conjunction with methaemoglobin-inducing medicinal products (e.g., sulphonamides, nitrofurantoin, phenytoin, phenobarbital). This list is not exhaustive.</p><p>With large doses of Lignox, consideration should be given to the risk of additional systemic toxicity in patients receiving other local anaesthetics or medicinal products structurally related to local anaesthetics, since the toxic effects are additive.</p><p>Specific interaction studies with lidocaine/prilocaine and anti-arrhythmics class III (e.g., amiodarone) have not been performed, but caution is advised (see also section 4.4).</p><p>Medicinal products that reduce the clearance of lidocaine (e.g., cimetidine or betablockers) may cause potentially toxic plasma concentrations when lidocaine is given in repeated high doses over a long time period.</p><p><em>Paediatric population</em><br />Specific interaction studies in children have not been performed. Interactions are likely to be similar to the adult population.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u><br />Although topical application is associated with only a low level of systemic absorption, the use of Lignox in pregnant women should be undertaken with care because insufficient data are available concerning the use of Lignox in pregnant women. However, animal studies do not indicate any direct or indirect negative effects on pregnancy, embryo-foetal development, parturition or postnatal development. Reproduction toxicity has been shown with subcutaneous/intramuscular administration of high doses of lidocaine or prilocaine much exceeding the exposure from topical application (see section 5.3).</p><p>Lidocaine and prilocaine cross the placental barrier and may be absorbed by the foetal tissues. It is reasonable to assume that lidocaine and prilocaine have been used in a large number of pregnant women and women of childbearing age. No specific disturbances to the reproductive process have so far been reported, e.g., an increased incidence of malformations or other directly or indirectly harmful effects on the foetus.</p><p><u>Breast-feeding</u><br />Lidocaine and, in all probability, prilocaine are excreted into breast milk, but in such small quantities that there is generally no risk of the child being affected at therapeutic dose levels. Lignox can be used during breast-feeding if clinically needed.</p><p><u>Fertility</u><br />Animal studies have shown no impairment of the fertility of male or female rats (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lignox has no or negligible influence on the ability to drive and use machines when used at the recommended doses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Summary of the safety profile</em><br />The most frequently observed adverse drug reactions (ADRs) are related to administration site conditions (transient local reactions at the application site), reported as common.</p><p><em>Tabulated list of adverse reactions</em><br />The incidences of the Adverse Drug Reactions (ADRs) associated with Lignox therapy is tabulated below. The table is based on adverse events reported during clinical trials, and/or post-marketing use. Their frequency of Adverse Reactions is listed by MedDRA System Organ Class (SOC) and at the preferred term level.</p><p>Within each System Organ Class, adverse reactions are listed under frequency categories of very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100), rare (&ge; 1/10,000 to &lt; 1/1,000), very rare (&lt; 1/10,000). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><p><strong>Table 3 Adverse reactions</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Methaemoglobinaemia<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity<sup>1, 2, 3</sup></p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Corneal irritation<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Purpura<sup>1</sup>, Petechiae<sup>1</sup> (especially after longer application times in children with atopic dermatitis or mollusca contagiosa)</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Burning sensation<sup>2, 3</sup><br />Application site pruritus<sup>2, 3</sup><br />Application site erythema<sup>1,2, 3</sup><br />Application site oedema<sup>1, 2, 3</sup><br />Application site warmth <sup>2, 3</sup><br />Application site pallor<sup>1, 2, 3</sup></p></td><td style="vertical-align:top"><p>Burning sensation<sup>1</sup><br />Application site irritation<sup>3</sup><br />Application site pruritus<sup>1</sup><br />Application site paraesthesia<sup>2</sup> such as tingling<br />Application site warmth<sup>1</sup></p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p><sup>1</sup> Skin<br /><sup>2</sup> Genital mucosa<br /><sup>3</sup> Leg ulcer</p><p><em>Paediatric population</em><br />Frequency, type and severity of adverse reactions are similar in the paediatric and adult age groups, except for methaemoglobinaemia, which is more frequently observed, often in connection with overdose (see section 4.9), in newborn infants and infants aged 0 to 12 months.</p><p><u>Reporting of suspected adverse reactions</u><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p><u>To reports any side effect(s):</u><br /><strong>Saudi Arabia:</strong></p><ul><li>The National Pharmacovigilance Centre (NPC):<ul><li>SFDA Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/</li></ul></li></ul><p><strong>Other GCC States:</strong></p><ul><li>Please contact the relevant competent authority.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Rare cases of clinically significant methaemoglobinaemia have been reported. Prilocaine in high doses may cause an increase in methaemoglobin levels particularly in susceptible individuals (section 4.4), with too frequent dosing in newborn infants and infants below 12 months of age (section 4.2) and in conjunction with methaemoglobin-inducing medicinal products (e.g., sulphonamides, nitrofurantoin, phenytoin and phenobarbital). Consideration should be given to the fact that pulse oximeter values may overestimate the actual oxygen saturation in case of increased methaemoglobin fraction; therefore, in cases of suspected methaemoglobinaemia, it may be more helpful to monitor oxygen saturation by co-oximetry.</p><p>Clinically significant methaemoglobinaemia should be treated with a slow intravenous injection of methylene blue (see also section 4.4).</p><p>Should other symptoms of systemic toxicity occur, the signs are anticipated to be similar in nature to those following the administration of local anaesthetics by other routes of administration. Local anaesthetic toxicity is manifested by symptoms of nervous system excitation and, in severe cases, central nervous and cardiovascular depression. Severe neurological symptoms (convulsions, CNS depression) must be treated symptomatically by respiratory support and the administration of anticonvulsive medicinal products; circulatory signs are treated in line with recommendations for resuscitation.</p><p>Since the rate of absorption from intact skin is slow, a patient showing signs of toxicity should be kept under observation for several hours following emergency treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: anaesthetics, local; amides<br />ATC code: N01B B20</p><p><u>Mechanism of action</u><br />Lignox provides dermal anaesthesia through the release of lidocaine and prilocaine from the cream into the epidermal and dermal layers of the skin and the vicinity of dermal pain receptors and nerve endings.</p><p>Lidocaine and prilocaine are amide-type local anaesthetics. They both stabilise neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby producing local anaesthesia. The quality of anaesthesia depends upon the application time and the dose.</p><p><u>Skin</u><br />Lignox is applied to intact skin under an occlusive dressing. The time needed to achieve reliable anaesthesia of intact skin is 1 to 2 hours, depending on the type of procedure. The local anaesthetic effect improves with longer application times from 1 to 2 hours in most parts of the body, with the exception of the skin of the face and the male genitals. Because of thin facial skin and high tissue blood flow, maximal local anaesthetic effect is obtained after 30 &ndash; 60 minutes on the forehead and on the cheeks. Similarly, local anaesthesia of the male genitals is achieved after 15 minutes. The duration of anaesthesia following the application of Lignox for 1 to 2 hours is at least 2 hours after removal of the dressing, except in the face where the duration is shorter. Lignox is equally effective and has the same anaesthetic onset time across the range of light to dark pigmented skin (skin types I to VI).</p><p>In clinical studies of Lignox on intact skin, no differences in safety or efficacy (including anaesthetic onset time) were observed between geriatric patients (aged 65 to 96 years) and younger patients.</p><p>Lignox produces a biphasic vascular response involving initial vasoconstriction followed by vasodilatation at the application site (see section 4.8). Irrespective of the vascular response, Lignox facilitates the needle procedure compared to placebo cream. In patients with atopic dermatitis, a similar but shorter vascular reaction is seen, with erythema occurring after 30 &ndash; 60 minutes, indicating more rapid absorption through the skin (see section 4.4). Lignox may cause a transient increase in skin thickness, partly caused by hydration of the skin under the occlusive dressing. The skin thickness decreases over the course of 15 minutes air exposure.</p><p>The depth of cutaneous anaesthesia increases with application time. In 90% of patients the anaesthesia is sufficient for the insertion of a biopsy punch (4 mm diameter) to a depth of 2 mm after 60 minutes and 3 mm after 120 minutes Lignox treatment.</p><p>The use of Lignox prior to measles-mumps-rubella or intramuscular diphtheria-pertussis-tetanus-inactivated poliovirus-Haemophilus influenzae b or Hepatitis B vaccines does not affect mean antibody titres, rate of seroconversion, or the proportion of patients achieving protective or positive antibody titres post immunisation, as compared to placebo treated patients.</p><p><u>Genital mucosa</u><br />Absorption from the genital mucosa is more rapid and onset time is shorter than after application to the skin.</p><p>After a 5 &ndash; 10 minute application of Lignox to female genital mucosa the average duration of effective analgesia to an argon laser stimulus, which produced a sharp, pricking pain was 15 &ndash; 20 minutes (individual variations in the range 5 &ndash; 45 minutes).</p><p><u>Leg ulcers</u><br />Reliable anaesthesia for the cleansing of leg ulcers is achieved after an application time of 30 minutes in most patients. An application time of 60 minutes may improve the anaesthesia further. The cleansing procedure should start within 10 minutes of removal of the cream. Clinical data from a longer waiting period are not available. Lignox reduces the postoperative pain for up to 4 hours after debridement. Lignox reduces the number of cleansing sessions required to achieve a clean ulcer compared to debridement with placebo cream. No negative effects on ulcer healing or bacterial flora have been observed.</p><p><u>Paediatric population</u><br />Clinical studies involved more than 2,300 paediatric patients of all age groups and demonstrated efficacy for needle pain (venipuncture, cannulation, s.c. and i.m. vaccinations, lumbar puncture), laser treatment of vascular lesions, and curettage of molluscum contagiosum. Lignox diminished the pain of both needle insertion and injection of vaccines. Analgesic efficacy increased from 15 to 90 minutes application on normal skin but on vascular lesions 90 minutes provided no benefit over 60 min. There was no benefit of Lignox versus placebo for liquid nitrogen cryotherapy of common warts. No adequate efficacy for circumcision could be demonstrated.</p><p>Eleven clinical studies in newborn infants and infants showed that peak methaemoglobin concentrations occur about 8 hours after epicutaneous Lignox administration, are clinically insignificant with recommended dosage, and return to normal values after about 12 &ndash; 13 hours. Methaemoglobin formation is related to the cumulative amount of prilocaine percutaneously absorbed, and may therefore increase with prolonged application times of Lignox.</p><p>The use of Lignox prior to measles-mumps-rubella or intramuscular diphtheria-pertussis-tetanus-inactivated poliovirus-Haemophilus influenzae b or Hepatitis B vaccines did not affect mean antibody titres, rate of seroconversion, or the proportion of patients achieving protective or positive antibody titres post immunisation, as compared to placebo treated patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption, distribution, biotransformation and elimination</u><br />The systemic absorption of lidocaine and prilocaine from Lignox is dependent upon the dose, area of application and application time. Additional factors include thickness of the skin (which varies in different areas of the body), other conditions such as skin diseases, and shaving. Following application to leg ulcers, the characteristics of the ulcers may also affect the absorption. Plasma concentrations after treatment with Lignox are 20 &ndash; 60% lower for prilocaine than for lidocaine, because of a larger volume of distribution and more rapid clearance. The major elimination pathway of lidocaine and prilocaine is via hepatic metabolism and metabolites are renally excreted. However, the rate of metabolism and elimination of the local anaesthetics after topical application of Lignox are governed by the rate of absorption. Therefore, a decrease in clearance, such as in patients with severely impaired liver function, has limited effects on the systemic plasma concentrations after a single dose of Lignox, and after single doses repeated once daily short term (up to 10 days).</p><p>Symptoms of local anaesthetic toxicity become increasingly apparent at increasing plasma concentration from 5 to 10 &mu;g/ml of either active substance. It should be assumed that the toxicity of lidocaine and prilocaine are additive.</p><p><em>Intact skin</em><br />Following application to the thigh in adults (60 g cream/400 cm<sup>2</sup> for 3 hours), the extent of absorption was approximately 5% of lidocaine and prilocaine. Maximum plasma concentrations (mean 0.12 and 0.07 &mu;g/ml) were reached approximately 2 &ndash; 6 hours after application.</p><p>The extent of systemic absorption was approximately 10% following application to the face (10 g/100 cm<sup>2</sup> for 2 hours). Maximum plasma concentrations (mean 0.16 and 0.06 &mu;g/ml) were reached after approximately 1.5 &ndash; 3 hours.</p><p>In studies of split-skin grafting in adults application for up to 7 hours 40 minutes to the thigh or upper arm to an area of up to 1,500 cm<sup>2</sup> resulted in maximum plasma concentrations not exceeding 1.1 &mu;g/ml lidocaine and 0.2 &mu;g/ml prilocaine.</p><p><em>Genital mucosa</em><br />After the application of 10 g Lignox for 10 minutes to vaginal mucosa, maximum plasma concentrations of lidocaine and prilocaine (mean 0.18 &mu;g/ml and 0.15 &mu;g/ml respectively) were reached after 20 &ndash; 45 minutes.</p><p><em>Leg ulcer</em><br />Following a single application of 5 to 10 g of Lignox to leg ulcers with an area of up to 64 cm2 for 30 minutes, the maximum plasma concentrations of lidocaine (range 0.05-0.25 &mu;g/ml, one individual value of 0.84 &mu;g/ml) and of prilocaine (0.02 &ndash; 0.08 &mu;g/ml) were reached within 1 to 2.5 hours.</p><p>After an application time of 24 hours to leg ulcers with an area of up to 50-100 cm<sup>2</sup>, the maximum plasma concentrations of lidocaine (0.19 &ndash; 0.71 &mu;g/ml) and of prilocaine (0.06 &ndash; 0.28 &mu;g/ml) were usually reached within 2 to 4 hours.</p><p>Following repeated application of 2 &ndash; 10 g Lignox to leg ulcers with an area of up to 62 cm<sup>2</sup> for 30 &ndash; 60 minutes 3 &ndash; 7 times a week for up to 15 doses during a period of one month, there was no apparent accumulation in plasma of lidocaine and its metabolites monoglycinexylidide and 2,6-xylidine or of prilocaine and its metabolite ortho-toluidine. The maximum observed plasma concentration for lidocaine, monoglycinexylidide and 2,6-xylidine were 0.41, 0.03 and 0.01 &mu;g/ml respectively. The maximum observed plasma concentrations for prilocaine and ortho-toluidine were 0.08 &mu;g/ml and 0.01 &mu;g/ml respectively.</p><p>Following repeated application of 10 g Lignox to chronic leg ulcers with an area between 62 &ndash; 160 cm<sup>2</sup> for 60 minutes once daily during 10 consecutive days, the mean maximum plasma concentration of the sum of lidocaine and prilocaine concentrations was 0.6 &mu;g/ml. The maximum concentration does not depend on the patient&acute;s age but is significantly (p&lt;0.01) related to the size of the ulcer area. Increasing the ulcer area by 1 cm<sup>2</sup> results in an increased C<sub>max</sub> for the sum of lidocaine and prilocaine concentrations of 7.2 ng/ml. The sum of the maximum plasma concentrations of lidocaine and prilocaine is less than one-third of those associated with toxic reactions, with no apparent accumulation over 10 days.</p><p><em>Special populations<br />Elderly patients</em><br />Plasma concentrations of lidocaine and prilocaine in both geriatric and non-geriatric patients following application of Lignox to intact skin are very low and well below potentially toxic levels.</p><p><em>Paediatric population</em><br />The maximum plasma concentrations of lidocaine and prilocaine after application of Lignox in paediatric patients of different ages were also below potentially toxic levels. See table 4.</p><p><strong>Table 4 Plasma concentrations of lidocaine and prilocaine in paediatric age groups from 0 months to 8 years of age</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td rowspan="2" style="vertical-align:top"><p><strong>Age</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>Applied amount of cream</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>Application time of the cream on the skin</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Plasma concentration</strong></p><p><strong>[ng/ml]</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Lidocaine</strong></p></td><td style="vertical-align:top"><p><strong>Prilocaine</strong></p></td></tr><tr><td style="vertical-align:top"><p>0 &ndash; 3 months</p></td><td style="vertical-align:top"><p>1 g/10 cm<sup>2</sup></p></td><td style="vertical-align:top"><p>1 hour</p></td><td style="vertical-align:top"><p>135</p></td><td style="vertical-align:top"><p>107</p></td></tr><tr><td style="vertical-align:top"><p>3 &ndash; 12 months</p></td><td style="vertical-align:top"><p>2 g/16 cm<sup>2</sup></p></td><td style="vertical-align:top"><p>4 hours</p></td><td style="vertical-align:top"><p>155</p></td><td style="vertical-align:top"><p>131</p></td></tr><tr><td style="vertical-align:top"><p>2 &ndash; 3 years</p></td><td style="vertical-align:top"><p>10 g/100 cm<sup>2</sup></p></td><td style="vertical-align:top"><p>2 hours</p></td><td style="vertical-align:top"><p>315</p></td><td style="vertical-align:top"><p>215</p></td></tr><tr><td style="vertical-align:top"><p>6 &ndash; 8 years</p></td><td style="vertical-align:top"><p>10 &ndash; 16 g/100 &ndash; 160 cm<sup>2</sup> (1 g/10 cm<sup>2</sup>)</p></td><td style="vertical-align:top"><p>2 hours</p></td><td style="vertical-align:top"><p>299</p></td><td style="vertical-align:top"><p>110</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal studies the toxicity noted after high doses of either lidocaine or prilocaine, alone or in combination, consisted of effects on the central nervous and cardiovascular systems. When lidocaine and prilocaine were combined, only additive effects were seen, with no indication of synergism or unexpected toxicity. Both active substances were shown to have a low oral acute toxicity, providing a good safety margin in the event that Lignox is inadvertently swallowed. In studies on reproduction toxicity, embryotoxic or fetotoxic effects of lidocaine were detected at doses of 25 mg/kg s.c. in the rabbit and for prilocaine starting at doses of 100 mg/kg i.m. in the rat. At doses below the maternal toxic range in the rat, lidocaine has no effect on the postnatal development of the offspring. An impairment of the fertility of male or female rats by lidocaine or prilocaine was not observed. Lidocaine crosses the placental barrier by means of simple diffusion. The ratio of the embryofetal dose to the maternal serum concentration is 0.4 to 1.3.</p><p>Neither local anaesthetic showed a genotoxic potential in either in vitro or in vivo genotoxicity tests. Cancer studies have not been performed with either lidocaine or prilocaine alone or in combination, due to the indication and duration of therapeutic use of these active substances.</p><p>A metabolite of lidocaine, 2,6-dimethylaniline, and a metabolite of prilocaine, &sigma;-toluidine, showed evidence of genotoxic activity. These metabolites have been shown to have carcinogenicity potential in preclinical toxicological studies evaluating chronic exposure. Risk assessments comparing the calculated maximum human exposure from intermittent use of lidocaine and prilocaine, with the exposure used in preclinical studies, indicate a wide margin of safety for clinical use.</p><p>Local tolerance studies using a 1:1 (w/w) mixture of lidocaine and prilocaine as an emulsion, cream or gel indicated that these formulations are well tolerated by intact and damaged skin and mucosal membranes.</p><p>A marked irritative reaction was seen after single ocular administration of a 50 mg/g lidocaine + prilocaine 1:1 (w/w) emulsion, in an animal study. This is the same concentration of local anaesthetics and a similar formulation as for Lignox. This ocular reaction may have been influenced by the high pH of the formulation of the emulsion (approximately 9), but is probably also partly a result of the irritative potential of the local anaesthetics themselves.<strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Macrogolglycerol hydroxystearate<br />Carbopol 974P<br />Sodium hydroxide<br />Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.<br />Do not freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 x 30 g aluminum tube.<br />1 x 5 g aluminum tube.<br />5 x 5 g aluminum tubes and 5 transparent film dressings.<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em><u>Precautions to be taken before handling or administering the medicinal product</u></em><br />Persons frequently applying or removing cream should ensure that contact is avoided in order to prevent the development of hypersensitivity.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Pharmaceutical Industries
P.O. Box No.: 355127, Riyadh 11383
Kingdom of Saudi Arabia.
Tel: (+96611) 2650450, 2650354
Fax: (+96611) 2650383
Email: info@saudi-pharma.net
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>